Skip to Main Content

Advertisement intended for health care professionals

Skip Nav Destination

ICAM-1–targeted thrombomodulin mitigates tissue factor–driven inflammatory thrombosis in a human endothelialized microfluidic model

Blood Adv (2017) 1 (18): 1452–1465.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals